Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Table 8

Comparison of AUROC curve values among non-fatty liver subjects with metabolic syndrome.

	AUROC	95% confidence interval	Standard error	P value
All subjects
FLI	0.879	0.872–0.885	0.003	<0.001
LAP	0.871	0.863–0.879	0.004	<0.001
Triglyceride	0.828	0.818–0.838	0.005	<0.001
WC	0.827	0.819–0.835	0.004	<0.001
HDL	0.822	0.832–0.813	0.005	<0.001
BMI	0.783	0.774–0.792	0.005	<0.001
Fasting glucose	0.774	0.762–0.785	0.006	<0.001
GGT	0.693	0.682–0.704	0.006	<0.001
Age	0.679	0.667–0.691	0.006	<0.001
ALT	0.619	0.607–0.631	0.006	<0.001
LDL	0.543	0.531–0.556	0.006	<0.001
Cholesterol	0.513	0.501–0.526	0.007	0.04
Female subjects
LAP	0.921	0.909–0.932	0.006	<0.001
FLI	0.909	0.898–0.921	0.006	<0.001
Triglyceride	0.860	0.842–0.878	0.009	<0.001
Fasting glucose	0.841	0.820–0.862	0.011	<0.001
WC	0.830	0.811–0.849	0.010	<0.001
HDL	0.822	0.841–0.803	0.010	<0.001
BMI	0.812	0.792–0.831	0.010	<0.001
Age	0.784	0.765–0.804	0.010	<0.001
GGT	0.673	0.650–0.697	0.012	<0.001
ALT	0.589	0.563–0.615	0.013	<0.001
LDL	0.574	0.548–0.600	0.013	<0.001
Cholesterol	0.547	0.520–0.574	0.014	<0.001
Male subjects
LAP	0.844	0.834–0.855	0.005	<0.001
FLI	0.814	0.803–0.825	0.005	<0.001
Triglyceride	0.787	0.774–0.801	0.007	<0.001
HDL	0.772	0.786–0.759	0.007	<0.001
WC	0.757	0.745–0.768	0.006	<0.001
Fasting glucose	0.738	0.724–0.753	0.007	<0.001
BMI	0.723	0.711–0.736	0.006	<0.001
Age	0.615	0.601–0.630	0.007	<0.001
GGT	0.615	0.600–0.630	0.008	<0.001
ALT	0.559	0.544–0.575	0.008	<0.001
Cholesterol	0.517	0.502–0.533	0.008	0.029
LDL	0.514	0.499–0.529	0.008	0.074

AUROC, area under the receiver operating characteristic; FLI, fatty liver index; LAP, lipid accumulation product; TG, triglyceride; WC, waist circumference; HDL, high-density lipoprotein; BMI, body mass index; GGT, gamma-glutamyl transferase; ALT, alanine aminotransferase; LDL, low-density lipoprotein.